Venrock Healthcare Capital Partners III, L.P. - Dec 31, 2024 SCHEDULE 13G/A Report for Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share (SYRE)

Filing Manager
Venrock Healthcare Capital Partners III, L.P.
Reporting Manager
Venrock Healthcare Capital Partners III, L.P.
Security
Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
SYRE
Shares outstanding
58.4M shares
Disclosed Ownership
2.69M shares
Ownership
4.6%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 06:06 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Venrock Healthcare Capital Partners III, L.P. 4.6% 2.69M 0 2.69M /s/ Sherman G. Souther By VHCP Management III, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
VHCP Co-Investment Holdings III, LLC 4.6% 2.69M 0 2.69M /s/ Sherman G. Souther By VHCP Management III, LLC, its Manager, By Sherman G. Souther, Authorized Signatory
Venrock Healthcare Capital Partners EG, L.P. 4.6% 2.69M 0 2.69M /s/ Sherman G. Souther By VHCP Management EG, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
VHCP Management III, LLC 4.6% 2.69M 0 2.69M /s/ Sherman G. Souther By Sherman G. Souther, Authorized Signatory
VHCP Management EG, LLC 4.6% 2.69M 0 2.69M /s/ Sherman G. Souther By Sherman G. Souther, Authorized Signatory
Nimish Shah 4.6% 2.69M 0 2.69M /s/ Sherman G. Souther By Sherman G. Souther, Attorney-in-fact
Bong Y Koh 4.6% 2.69M 0 2.69M /s/ Sherman G. Souther By Sherman G. Souther, Attorney-in-fact